UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929

2017

Volltextzugriff (PDF)

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177

2014

Volltextzugriff (PDF)

Alectinib in ALK -positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

The lancet oncology, 2016-02, Vol.17 (2), p.234-242

2016

Volltextzugriff (PDF)

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350

2018

Volltextzugriff (PDF)

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2251-2258

2018

Volltextzugriff (PDF)

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.661-668

2016

Volltextzugriff (PDF)

Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade: A Key Player Against Various Cancers

Archives of pathology & laboratory medicine (1976), 2017-06, Vol.141 (6), p.851-861

2017

Volltextzugriff (PDF)

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Nature medicine, 2022-05, Vol.28 (5), p.939-945

2022

Volltextzugriff (PDF)

Numerical study of the effect of changing the cyclone cone length on the gas flow field

Applied Mathematical Modelling, 2017-06, Vol.46, p.81-97

2017

Volltextzugriff (PDF)

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2005-02, Vol.23 (4), p.832-841

2005

Volltextzugriff (PDF)

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy

Journal of clinical oncology, 2009-01, Vol.27 (2), p.235-241

2009

Volltextzugriff (PDF)

Thermal performance evaluation of various nanofluids with non-uniform heating for parabolic trough collectors

Case studies in thermal engineering, 2020-12, Vol.22, p.100769, Article 100769

2020

Volltextzugriff (PDF)

Performance enhancement of photovoltaic panel by using microencapsulated phase change slurry in channel with staggered pins

Numerical heat transfer. Part A, Applications, 2023-07, Vol.84 (2), p.156-175

2023

Volltextzugriff (PDF)

Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression

Molecular cancer therapeutics, 2010-08, Vol.9 (8), p.2309-2321

2010

Volltextzugriff (PDF)

Effect of wind speed over the chimney on the updraft velocity of a solar chimney power plant: An experimental study

Case studies in thermal engineering, 2022-09, Vol.37, p.102265, Article 102265

2022

Volltextzugriff (PDF)

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

Clinical cancer research, 2009-04, Vol.15 (7), p.2552-2558

2009

Volltextzugriff (PDF)

Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study

Supportive care in cancer, 2021-01, Vol.29 (1), p.117-125

2021

Volltextzugriff (PDF)

Paclitaxel in cancer therapy

Expert opinion on pharmacotherapy, 2002-06, Vol.3 (6), p.755-766

2002

Volltextzugriff (PDF)

Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report

The American journal of case reports, 2017-07, Vol.18, p.799-804

2017

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2015-11, Vol.20 (11), p.1298-1303

2015

Volltextzugriff (PDF)

A numerical comparative study of axial flow turbines for solar chimney power plant

Case studies in thermal engineering, 2021-08, Vol.26, p.101046, Article 101046

2021

Volltextzugriff (PDF)

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12001-12001

2018

Volltextzugriff (PDF)

A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience

Journal of thoracic oncology, 2009-08, Vol.4 (8), p.976-982

2009

Volltextzugriff (PDF)

Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol

Clinical lung cancer, 2019-05, Vol.20 (3), p.e407-e412

2019

Volltextzugriff (PDF)

First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)

Cancer investigation, 2017-09, Vol.35 (8), p.541-546

2017

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Englisch
(180)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(93)
Humans
(88)
Oncology
(72)
Female
(66)
Male
(59)
Aged
(56)
Middle Aged
(56)
Adult
(43)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Lung Neoplasms - Drug Therapy
(28)
Tumors
(28)
Lung Cancer
(26)
Lung Neoplasms - Pathology
(25)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(24)
Treatment Outcome
(24)
Aged, 80 And Over
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Chemotherapy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Alectinib in ALK -positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade: A Key Player Against Various Cancers

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Numerical study of the effect of changing the cyclone cone length on the gas flow field

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy

Thermal performance evaluation of various nanofluids with non-uniform heating for parabolic trough collectors

Performance enhancement of photovoltaic panel by using microencapsulated phase change slurry in channel with staggered pins

Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression

Effect of wind speed over the chimney on the updraft velocity of a solar chimney power plant: An experimental study

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study

Paclitaxel in cancer therapy

Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer

A numerical comparative study of axial flow turbines for solar chimney power plant

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results

A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience

Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol

First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)

Suchergebnisse filtern